Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

A

AFPJJIM

@AFPJJIM
Manufacturer

Forum Update: Supporting Community-Led Discussion

The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.

Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:

  • Correct any misunderstandings
  • Provide guidance when questions remain unanswered after a few days
  • Support discussions where official clarification is needed

Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.

Thank you for being part of the conversation.

About
Posts
6
Topics
3
Shares
0
Groups
1
Followers
1
Following
0

Posts

Recent Best Controversial

  • Email Attachments
    A AFPJJIM

    Hi @jennifer-carroll,

    Thank you for the helpful response. One additional question regarding the naming convention that I did not see covered was the possibility of not including indication information but potentially having the study name instead.

    For example, if a brand is indicated across different therapeutic areas is it possible to include the study name as part of the naming convention e.g. (FOREST_Study_Leave_Behind). I ask as this does not include any claims information but I was unsure if this would be generic enough to be included in a generic email template if potentially used across brands.

    I'm thinking if there were say two or three different brands and the email was structured to be a genericized template and the attachment appear as below (assuming FOREST, BEACH, MOUNTAIN are trials belonging to 3 different brands);

    FOREST_Study_Efficacy
    BEACH_Study_Safety
    MOUNTAIN_Study_Efficacy

    Is this brand agnostic enough that a generic template could still be used?

    PAAB Code

  • Email Attachments
    A AFPJJIM

    Administrator repositioned question due to relevance to this thread:

    I am curious if when attaching different APS to a generic email template (no branding just generic greeting, date and time of meeting and sign-off) does each combination of APS need to be approved or will the email template and each individual APS approval be sufficient.

    For example, if we have APS attachments 1,2,3,4,5 does each combination within these APS need to be independently approved (i.e combo 1,3,5 and 2,4,3 need separate approval) or because all APS are independently approved and balanced does that approval suffice?

    PAAB Code

  • Email Attachments
    A AFPJJIM

    If there is a general email template created for a company with basic information (e.g. greeting, date and time of phone meeting, sign-off), can there be APS attached from multiple brands given those APS are individually approved and balanced? i.e. if we are looking to respond after a call discussing multiple products in one disease area are we able to attach APS from multiple brands if they are solicited in response to the previous discussion?

    PAAB Code
  • Login

  • Don't have an account? Register

  • Login or register to search.
  • First post
    Last post
0
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups